Summary

The global CircRNA Synthesis Service market is projected to grow from US$ 48.66 million in 2025 to US$ 160 million by 2032, at a CAGR of 16.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
CircRNA synthesis services are outsourced solutions that convert a customer-defined coding or non-coding sequence into purified circular RNA. A typical workflow includes sequence and circularization design, template preparation, in-vitro transcription, circularization, removal of residual linear RNA and double-stranded RNA impurities, purification, identity and junction confirmation, circularity analysis, concentration testing and final delivery. Services range from small research-scale projects to preclinical process development and regulated clinical-grade manufacturing. In 2025, the average gross margin at approximately 54%.Upstream suppliers provide DNA templates, nucleotides, polymerases, ligases, nucleases, purification media, analytical reagents and RNase-free consumables. Midstream service providers conduct sequence design, transcription, circularization, purification, quality control and final delivery. Downstream customers include pharmaceutical and biotechnology companies, research institutions, clinical-development organizations and diagnostic developers. Demand is driven by RNA-therapy research, outsourced development and repeated construct screening.
Demand is moving from proof-of-concept studies toward translational and preclinical programs, increasing requirements for purity, batch reproducibility, scale-up and documented quality control.
The closed-loop structure supports longer intracellular persistence and sustained expression, but circularization efficiency, residual linear RNA, double-stranded impurities and functional consistency remain major technical constraints.
Customers increasingly prefer integrated workflows covering design, template preparation, synthesis, purification and quality testing. Delivery formulation is often purchased together, although only the synthesis-related revenue is included in this market.
Quality standards are becoming more important as projects advance toward clinical development. Junction identity, circularity, impurity profiles, sterility and potency testing are emerging as key service differentiators.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global CircRNA Synthesis Service market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
GenScript Biotech Corporation
VectorBuilder Inc.
Guangzhou Geneseed Biotech Co., Ltd.
uBriGene Biosciences Inc.
Yaohai Bio-Pharma
Azenta Life Sciences (GENEWIZ)
GeneCopoeia, Inc.
Sangon Biotech (Shanghai) Co., Ltd.
Jiangsu GeneCFPS Biotech Co., Ltd.
Creative Biogene
Creative Biolabs
BOC Sciences
Segment by Type
Chemical Synthesis Method
Ligase Method
Ribozyme Method
Segment by Primary Service Type
Custom Synthesis
Process Development and Scale-Up
Analytical and QC Services
GMP Manufacturing
Segment by Circular RNA Length
Up to 100 nt
101–1,000 nt
1,001–5,000 nt
Above 5,000 nt
Segment by Application
Drug Discovery
Cell Therapy
Vaccine R&D
Disease Mechanism
Segment by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the CircRNA Synthesis Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to CircRNA Synthesis Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global CircRNA Synthesis Service Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Chemical Synthesis Method
1.2.3 Ligase Method
1.2.4 Ribozyme Method
1.3 Market Segmentation by Primary Service Type
1.3.1 Global CircRNA Synthesis Service Market Size by Primary Service Type, 2021 vs 2025 vs 2032
1.3.2 Custom Synthesis
1.3.3 Process Development and Scale-Up
1.3.4 Analytical and QC Services
1.3.5 GMP Manufacturing
1.4 Market Segmentation by Circular RNA Length
1.4.1 Global CircRNA Synthesis Service Market Size by Circular RNA Length, 2021 vs 2025 vs 2032
1.4.2 Up to 100 nt
1.4.3 101–1,000 nt
1.4.4 1,001–5,000 nt
1.4.5 Above 5,000 nt
1.5 Market Segmentation by Application
1.5.1 Global CircRNA Synthesis Service Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Drug Discovery
1.5.3 Cell Therapy
1.5.4 Vaccine R&D
1.5.5 Disease Mechanism
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global CircRNA Synthesis Service Revenue Estimates and Forecasts (2021-2032)
2.2 Global CircRNA Synthesis Service Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competitive Landscape
3.1 Global CircRNA Synthesis Service Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global CircRNA Synthesis Service Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Chemical Synthesis Method: Market Share by Key Players
3.3.2 Ligase Method: Market Share by Key Players
3.3.3 Ribozyme Method: Market Share by Key Players
3.4 Global CircRNA Synthesis Service Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Product Segmentation
4.1 Global CircRNA Synthesis Service Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Global CircRNA Synthesis Service Market by Primary Service Type
4.2.1 Global Revenue by Primary Service Type (2021-2032)
4.2.2 Global Revenue-Based Market Share by Primary Service Type (2021-2032)
4.3 Global CircRNA Synthesis Service Market by Circular RNA Length
4.3.1 Global Revenue by Circular RNA Length (2021-2032)
4.3.2 Global Revenue-Based Market Share by Circular RNA Length (2021-2032)
4.4 Key Product Attributes and Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global CircRNA Synthesis Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America CircRNA Synthesis Service Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America CircRNA Synthesis Service Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico
7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe CircRNA Synthesis Service Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe CircRNA Synthesis Service Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific CircRNA Synthesis Service Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific CircRNA Synthesis Service Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America CircRNA Synthesis Service Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America CircRNA Synthesis Service Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa CircRNA Synthesis Service Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa CircRNA Synthesis Service Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 GenScript Biotech Corporation
11.1.1 GenScript Biotech Corporation Corporation Information
11.1.2 GenScript Biotech Corporation Business Overview
11.1.3 GenScript Biotech Corporation CircRNA Synthesis Service Product Features and Attributes
11.1.4 GenScript Biotech Corporation CircRNA Synthesis Service Revenue and Gross Margin (2021-2026)
11.1.5 GenScript Biotech Corporation CircRNA Synthesis Service Revenue by Product in 2025
11.1.6 GenScript Biotech Corporation CircRNA Synthesis Service Revenue by Application in 2025
11.1.7 GenScript Biotech Corporation CircRNA Synthesis Service Revenue by Geographic Area in 2025
11.1.8 GenScript Biotech Corporation CircRNA Synthesis Service SWOT Analysis
11.1.9 GenScript Biotech Corporation Recent Developments
11.2 VectorBuilder Inc.
11.2.1 VectorBuilder Inc. Corporation Information
11.2.2 VectorBuilder Inc. Business Overview
11.2.3 VectorBuilder Inc. CircRNA Synthesis Service Product Features and Attributes
11.2.4 VectorBuilder Inc. CircRNA Synthesis Service Revenue and Gross Margin (2021-2026)
11.2.5 VectorBuilder Inc. CircRNA Synthesis Service Revenue by Product in 2025
11.2.6 VectorBuilder Inc. CircRNA Synthesis Service Revenue by Application in 2025
11.2.7 VectorBuilder Inc. CircRNA Synthesis Service Revenue by Geographic Area in 2025
11.2.8 VectorBuilder Inc. CircRNA Synthesis Service SWOT Analysis
11.2.9 VectorBuilder Inc. Recent Developments
11.3 Guangzhou Geneseed Biotech Co., Ltd.
11.3.1 Guangzhou Geneseed Biotech Co., Ltd. Corporation Information
11.3.2 Guangzhou Geneseed Biotech Co., Ltd. Business Overview
11.3.3 Guangzhou Geneseed Biotech Co., Ltd. CircRNA Synthesis Service Product Features and Attributes
11.3.4 Guangzhou Geneseed Biotech Co., Ltd. CircRNA Synthesis Service Revenue and Gross Margin (2021-2026)
11.3.5 Guangzhou Geneseed Biotech Co., Ltd. CircRNA Synthesis Service Revenue by Product in 2025
11.3.6 Guangzhou Geneseed Biotech Co., Ltd. CircRNA Synthesis Service Revenue by Application in 2025
11.3.7 Guangzhou Geneseed Biotech Co., Ltd. CircRNA Synthesis Service Revenue by Geographic Area in 2025
11.3.8 Guangzhou Geneseed Biotech Co., Ltd. CircRNA Synthesis Service SWOT Analysis
11.3.9 Guangzhou Geneseed Biotech Co., Ltd. Recent Developments
11.4 uBriGene Biosciences Inc.
11.4.1 uBriGene Biosciences Inc. Corporation Information
11.4.2 uBriGene Biosciences Inc. Business Overview
11.4.3 uBriGene Biosciences Inc. CircRNA Synthesis Service Product Features and Attributes
11.4.4 uBriGene Biosciences Inc. CircRNA Synthesis Service Revenue and Gross Margin (2021-2026)
11.4.5 uBriGene Biosciences Inc. CircRNA Synthesis Service Revenue by Product in 2025
11.4.6 uBriGene Biosciences Inc. CircRNA Synthesis Service Revenue by Application in 2025
11.4.7 uBriGene Biosciences Inc. CircRNA Synthesis Service Revenue by Geographic Area in 2025
11.4.8 uBriGene Biosciences Inc. CircRNA Synthesis Service SWOT Analysis
11.4.9 uBriGene Biosciences Inc. Recent Developments
11.5 Yaohai Bio-Pharma
11.5.1 Yaohai Bio-Pharma Corporation Information
11.5.2 Yaohai Bio-Pharma Business Overview
11.5.3 Yaohai Bio-Pharma CircRNA Synthesis Service Product Features and Attributes
11.5.4 Yaohai Bio-Pharma CircRNA Synthesis Service Revenue and Gross Margin (2021-2026)
11.5.5 Yaohai Bio-Pharma CircRNA Synthesis Service Revenue by Product in 2025
11.5.6 Yaohai Bio-Pharma CircRNA Synthesis Service Revenue by Application in 2025
11.5.7 Yaohai Bio-Pharma CircRNA Synthesis Service Revenue by Geographic Area in 2025
11.5.8 Yaohai Bio-Pharma CircRNA Synthesis Service SWOT Analysis
11.5.9 Yaohai Bio-Pharma Recent Developments
11.6 Azenta Life Sciences (GENEWIZ)
11.6.1 Azenta Life Sciences (GENEWIZ) Corporation Information
11.6.2 Azenta Life Sciences (GENEWIZ) Business Overview
11.6.3 Azenta Life Sciences (GENEWIZ) CircRNA Synthesis Service Product Features and Attributes
11.6.4 Azenta Life Sciences (GENEWIZ) CircRNA Synthesis Service Revenue and Gross Margin (2021-2026)
11.6.5 Azenta Life Sciences (GENEWIZ) Recent Developments
11.7 GeneCopoeia, Inc.
11.7.1 GeneCopoeia, Inc. Corporation Information
11.7.2 GeneCopoeia, Inc. Business Overview
11.7.3 GeneCopoeia, Inc. CircRNA Synthesis Service Product Features and Attributes
11.7.4 GeneCopoeia, Inc. CircRNA Synthesis Service Revenue and Gross Margin (2021-2026)
11.7.5 GeneCopoeia, Inc. Recent Developments
11.8 Sangon Biotech (Shanghai) Co., Ltd.
11.8.1 Sangon Biotech (Shanghai) Co., Ltd. Corporation Information
11.8.2 Sangon Biotech (Shanghai) Co., Ltd. Business Overview
11.8.3 Sangon Biotech (Shanghai) Co., Ltd. CircRNA Synthesis Service Product Features and Attributes
11.8.4 Sangon Biotech (Shanghai) Co., Ltd. CircRNA Synthesis Service Revenue and Gross Margin (2021-2026)
11.8.5 Sangon Biotech (Shanghai) Co., Ltd. Recent Developments
11.9 Jiangsu GeneCFPS Biotech Co., Ltd.
11.9.1 Jiangsu GeneCFPS Biotech Co., Ltd. Corporation Information
11.9.2 Jiangsu GeneCFPS Biotech Co., Ltd. Business Overview
11.9.3 Jiangsu GeneCFPS Biotech Co., Ltd. CircRNA Synthesis Service Product Features and Attributes
11.9.4 Jiangsu GeneCFPS Biotech Co., Ltd. CircRNA Synthesis Service Revenue and Gross Margin (2021-2026)
11.9.5 Jiangsu GeneCFPS Biotech Co., Ltd. Recent Developments
11.10 Creative Biogene
11.10.1 Creative Biogene Corporation Information
11.10.2 Creative Biogene Business Overview
11.10.3 Creative Biogene CircRNA Synthesis Service Product Features and Attributes
11.10.4 Creative Biogene CircRNA Synthesis Service Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 Creative Biolabs
11.11.1 Creative Biolabs Corporation Information
11.11.2 Creative Biolabs Business Overview
11.11.3 Creative Biolabs CircRNA Synthesis Service Product Features and Attributes
11.11.4 Creative Biolabs CircRNA Synthesis Service Revenue and Gross Margin (2021-2026)
11.11.5 Creative Biolabs Recent Developments
11.12 BOC Sciences
11.12.1 BOC Sciences Corporation Information
11.12.2 BOC Sciences Business Overview
11.12.3 BOC Sciences CircRNA Synthesis Service Product Features and Attributes
11.12.4 BOC Sciences CircRNA Synthesis Service Revenue and Gross Margin (2021-2026)
11.12.5 BOC Sciences Recent Developments
12 CircRNA Synthesis Service Value Chain and Ecosystem Analysis
12.1 CircRNA Synthesis Service Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 CircRNA Synthesis Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global CircRNA Synthesis Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global CircRNA Synthesis Service Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global CircRNA Synthesis Service Market Size Growth Rate by Primary Service Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global CircRNA Synthesis Service Market Size Growth Rate by Circular RNA Length, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global CircRNA Synthesis Service Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global CircRNA Synthesis Service Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global CircRNA Synthesis Service Revenue by Region (US$ Million), 2021-2026
Table 7. Global CircRNA Synthesis Service Revenue by Region (US$ Million), 2027-2032
Table 8. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 9. Global CircRNA Synthesis Service Revenue by Players (US$ Million), 2021-2026
Table 10. Global CircRNA Synthesis Service Revenue-Based Market Share by Players (2021-2026)
Table 11. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 12. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on CircRNA Synthesis Service Revenue, 2025
Table 13. Global CircRNA Synthesis Service Average Gross Margin (%) by Player (2021 vs 2025)
Table 14. Global CircRNA Synthesis Service Companies Headquarters
Table 15. Global CircRNA Synthesis Service Market Concentration Ratio (CR5)
Table 16. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 17. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 18. Global CircRNA Synthesis Service Revenue by Type (US$ Million), 2021-2026
Table 19. Global CircRNA Synthesis Service Revenue by Type (US$ Million), 2027-2032
Table 20. Global CircRNA Synthesis Service Revenue by Primary Service Type (US$ Million), 2021-2026
Table 21. Global CircRNA Synthesis Service Revenue by Primary Service Type (US$ Million), 2027-2032
Table 22. Global CircRNA Synthesis Service Revenue by Circular RNA Length (US$ Million), 2021-2026
Table 23. Global CircRNA Synthesis Service Revenue by Circular RNA Length (US$ Million), 2027-2032
Table 24. Key Product Attributes and Differentiation
Table 25. Global CircRNA Synthesis Service Revenue by Application (US$ Million), 2021-2026
Table 26. Global CircRNA Synthesis Service Revenue by Application (US$ Million), 2027-2032
Table 27. CircRNA Synthesis Service High-Growth Sectors Demand CAGR (2026-2032)
Table 28. Top Customers by Region
Table 29. Top Customers by Application
Table 30. North America CircRNA Synthesis Service Growth Accelerators and Market Barriers
Table 31. North America CircRNA Synthesis Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Europe CircRNA Synthesis Service Growth Accelerators and Market Barriers
Table 33. Europe CircRNA Synthesis Service Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 34. Asia-Pacific CircRNA Synthesis Service Growth Accelerators and Market Barriers
Table 35. Asia-Pacific CircRNA Synthesis Service Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Central and South America CircRNA Synthesis Service Investment Opportunities and Key Challenges
Table 37. Central and South America CircRNA Synthesis Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 38. Middle East and Africa CircRNA Synthesis Service Investment Opportunities and Key Challenges
Table 39. Middle East and Africa CircRNA Synthesis Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 40. GenScript Biotech Corporation Corporation Information
Table 41. GenScript Biotech Corporation Description and Major Businesses
Table 42. GenScript Biotech Corporation Product Features and Attributes
Table 43. GenScript Biotech Corporation Revenue (US$ Million) and Gross Margin (2021-2026)
Table 44. GenScript Biotech Corporation Revenue Proportion by Product in 2025
Table 45. GenScript Biotech Corporation Revenue Proportion by Application in 2025
Table 46. GenScript Biotech Corporation Revenue Proportion by Geographic Area in 2025
Table 47. GenScript Biotech Corporation CircRNA Synthesis Service SWOT Analysis
Table 48. GenScript Biotech Corporation Recent Developments
Table 49. VectorBuilder Inc. Corporation Information
Table 50. VectorBuilder Inc. Description and Major Businesses
Table 51. VectorBuilder Inc. Product Features and Attributes
Table 52. VectorBuilder Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 53. VectorBuilder Inc. Revenue Proportion by Product in 2025
Table 54. VectorBuilder Inc. Revenue Proportion by Application in 2025
Table 55. VectorBuilder Inc. Revenue Proportion by Geographic Area in 2025
Table 56. VectorBuilder Inc. CircRNA Synthesis Service SWOT Analysis
Table 57. VectorBuilder Inc. Recent Developments
Table 58. Guangzhou Geneseed Biotech Co., Ltd. Corporation Information
Table 59. Guangzhou Geneseed Biotech Co., Ltd. Description and Major Businesses
Table 60. Guangzhou Geneseed Biotech Co., Ltd. Product Features and Attributes
Table 61. Guangzhou Geneseed Biotech Co., Ltd. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 62. Guangzhou Geneseed Biotech Co., Ltd. Revenue Proportion by Product in 2025
Table 63. Guangzhou Geneseed Biotech Co., Ltd. Revenue Proportion by Application in 2025
Table 64. Guangzhou Geneseed Biotech Co., Ltd. Revenue Proportion by Geographic Area in 2025
Table 65. Guangzhou Geneseed Biotech Co., Ltd. CircRNA Synthesis Service SWOT Analysis
Table 66. Guangzhou Geneseed Biotech Co., Ltd. Recent Developments
Table 67. uBriGene Biosciences Inc. Corporation Information
Table 68. uBriGene Biosciences Inc. Description and Major Businesses
Table 69. uBriGene Biosciences Inc. Product Features and Attributes
Table 70. uBriGene Biosciences Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 71. uBriGene Biosciences Inc. Revenue Proportion by Product in 2025
Table 72. uBriGene Biosciences Inc. Revenue Proportion by Application in 2025
Table 73. uBriGene Biosciences Inc. Revenue Proportion by Geographic Area in 2025
Table 74. uBriGene Biosciences Inc. CircRNA Synthesis Service SWOT Analysis
Table 75. uBriGene Biosciences Inc. Recent Developments
Table 76. Yaohai Bio-Pharma Corporation Information
Table 77. Yaohai Bio-Pharma Description and Major Businesses
Table 78. Yaohai Bio-Pharma Product Features and Attributes
Table 79. Yaohai Bio-Pharma Revenue (US$ Million) and Gross Margin (2021-2026)
Table 80. Yaohai Bio-Pharma Revenue Proportion by Product in 2025
Table 81. Yaohai Bio-Pharma Revenue Proportion by Application in 2025
Table 82. Yaohai Bio-Pharma Revenue Proportion by Geographic Area in 2025
Table 83. Yaohai Bio-Pharma CircRNA Synthesis Service SWOT Analysis
Table 84. Yaohai Bio-Pharma Recent Developments
Table 85. Azenta Life Sciences (GENEWIZ) Corporation Information
Table 86. Azenta Life Sciences (GENEWIZ) Description and Major Businesses
Table 87. Azenta Life Sciences (GENEWIZ) Product Features and Attributes
Table 88. Azenta Life Sciences (GENEWIZ) Revenue (US$ Million) and Gross Margin (2021-2026)
Table 89. Azenta Life Sciences (GENEWIZ) Recent Developments
Table 90. GeneCopoeia, Inc. Corporation Information
Table 91. GeneCopoeia, Inc. Description and Major Businesses
Table 92. GeneCopoeia, Inc. Product Features and Attributes
Table 93. GeneCopoeia, Inc. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 94. GeneCopoeia, Inc. Recent Developments
Table 95. Sangon Biotech (Shanghai) Co., Ltd. Corporation Information
Table 96. Sangon Biotech (Shanghai) Co., Ltd. Description and Major Businesses
Table 97. Sangon Biotech (Shanghai) Co., Ltd. Product Features and Attributes
Table 98. Sangon Biotech (Shanghai) Co., Ltd. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 99. Sangon Biotech (Shanghai) Co., Ltd. Recent Developments
Table 100. Jiangsu GeneCFPS Biotech Co., Ltd. Corporation Information
Table 101. Jiangsu GeneCFPS Biotech Co., Ltd. Description and Major Businesses
Table 102. Jiangsu GeneCFPS Biotech Co., Ltd. Product Features and Attributes
Table 103. Jiangsu GeneCFPS Biotech Co., Ltd. Revenue (US$ Million) and Gross Margin (2021-2026)
Table 104. Jiangsu GeneCFPS Biotech Co., Ltd. Recent Developments
Table 105. Creative Biogene Corporation Information
Table 106. Creative Biogene Description and Major Businesses
Table 107. Creative Biogene Product Features and Attributes
Table 108. Creative Biogene Revenue (US$ Million) and Gross Margin (2021-2026)
Table 109. Creative Biogene Recent Developments
Table 110. Creative Biolabs Corporation Information
Table 111. Creative Biolabs Description and Major Businesses
Table 112. Creative Biolabs Product Features and Attributes
Table 113. Creative Biolabs Revenue (US$ Million) and Gross Margin (2021-2026)
Table 114. Creative Biolabs Recent Developments
Table 115. BOC Sciences Corporation Information
Table 116. BOC Sciences Description and Major Businesses
Table 117. BOC Sciences Product Features and Attributes
Table 118. BOC Sciences Revenue (US$ Million) and Gross Margin (2021-2026)
Table 119. BOC Sciences Recent Developments
Table 120. Technologies, Platforms and Infrastructure
Table 121. Distributors List
Table 122. Market Trends and Market Evolution
Table 123. Market Drivers and Opportunities
Table 124. Market Challenges, Risks, and Restraints
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources


List of Figures
Figure 1. Global CircRNA Synthesis Service Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Chemical Synthesis Method Product Picture
Figure 3. Ligase Method Product Picture
Figure 4. Ribozyme Method Product Picture
Figure 5. Global CircRNA Synthesis Service Market Size Growth Rate by Primary Service Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Custom Synthesis Product Picture
Figure 7. Process Development and Scale-Up Product Picture
Figure 8. Analytical and QC Services Product Picture
Figure 9. GMP Manufacturing Product Picture
Figure 10. Global CircRNA Synthesis Service Market Size Growth Rate by Circular RNA Length, 2021 vs 2025 vs 2032 (US$ Million)
Figure 11. Up to 100 nt Product Picture
Figure 12. 101–1,000 nt Product Picture
Figure 13. 1,001–5,000 nt Product Picture
Figure 14. Above 5,000 nt Product Picture
Figure 15. Global CircRNA Synthesis Service Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 16. Drug Discovery
Figure 17. Cell Therapy
Figure 18. Vaccine R&D
Figure 19. Disease Mechanism
Figure 20. CircRNA Synthesis Service Report Years Considered
Figure 21. Global CircRNA Synthesis Service Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 23. Global CircRNA Synthesis Service Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 24. Global CircRNA Synthesis Service Revenue-Based Market Share by Region (2021-2032)
Figure 25. Global CircRNA Synthesis Service Revenue-Based Market Share Ranking (2025)
Figure 26. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 27. Chemical Synthesis Method Revenue-Based Market Share by Player in 2025
Figure 28. Ligase Method Revenue-Based Market Share by Player in 2025
Figure 29. Ribozyme Method Revenue-Based Market Share by Player in 2025
Figure 30. Global CircRNA Synthesis Service Revenue-Based Market Share by Type (2021-2032)
Figure 31. Global CircRNA Synthesis Service Revenue-Based Market Share by Primary Service Type (2021-2032)
Figure 32. Global CircRNA Synthesis Service Revenue-Based Market Share by Circular RNA Length (2021-2032)
Figure 33. Global CircRNA Synthesis Service Revenue-Based Market Share by Application (2021-2032)
Figure 34. North America CircRNA Synthesis Service Revenue YoY (US$ Million), 2021-2032
Figure 35. North America Top 5 Players CircRNA Synthesis Service Revenue (US$ Million) in 2025
Figure 36. North America CircRNA Synthesis Service Revenue (US$ Million) by Application (2021-2032)
Figure 37. US CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 38. Canada CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 39. Mexico CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 40. Europe CircRNA Synthesis Service Revenue YoY (US$ Million), 2021-2032
Figure 41. Europe Top 5 Players CircRNA Synthesis Service Revenue (US$ Million) in 2025
Figure 42. Europe CircRNA Synthesis Service Revenue (US$ Million) by Application (2021-2032)
Figure 43. Germany CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 44. France CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 45. U.K. CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 46. Italy CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 47. Russia CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 48. Asia-Pacific CircRNA Synthesis Service Revenue YoY (US$ Million), 2021-2032
Figure 49. Asia-Pacific Top 8 Players CircRNA Synthesis Service Revenue (US$ Million) in 2025
Figure 50. Asia-Pacific CircRNA Synthesis Service Revenue (US$ Million) by Application (2021-2032)
Figure 51. Indonesia CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 52. Japan CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 53. South Korea CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 54. Australia CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 55. India CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 56. Indonesia CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 57. Vietnam CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 58. Malaysia CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 59. Philippines CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 60. Singapore CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 61. Central and South America CircRNA Synthesis Service Revenue YoY (US$ Million), 2021-2032
Figure 62. Central and South America Top 5 Players CircRNA Synthesis Service Revenue (US$ Million) in 2025
Figure 63. Central and South America CircRNA Synthesis Service Revenue (US$ Million) by Application (2021-2032)
Figure 64. Brazil CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 65. Argentina CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 66. Middle East and Africa CircRNA Synthesis Service Revenue YoY (US$ Million), 2021-2032
Figure 67. Middle East and Africa Top 5 Players CircRNA Synthesis Service Revenue (US$ Million) in 2025
Figure 68. Middle East and Africa CircRNA Synthesis Service Revenue (US$ Million) by Application (2021-2032)
Figure 69. GCC Countries CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 70. Israel CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 71. Egypt CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 72. South Africa CircRNA Synthesis Service Revenue (US$ Million), 2021-2032
Figure 73. CircRNA Synthesis Service Value Chain Mapping
Figure 74. Channels of Distribution (Direct Vs Distribution)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed